Benzinga's Top Upgrades
Analysts at Citigroup upgraded Biogen Idec (NASDAQ: BIIB) from “neutral” to “buy.” The target price for Biogen Idec is set to $236. Biogen Idec's shares closed at $215.20 on Friday.
Analysts at Piper Jaffray upgraded Regeneron Pharmaceuticals (NASDAQ: REGN) from “neutral” to “overweight.” The target price for Regeneron Pharmaceuticals is set to $274. Regeneron's shares closed at $224.88 on Friday.
Analysts at Morgan Stanley upgraded Whitewave Foods (NYSE: WWAV) from “equal-weight” to “overweight.” The target price for Whitewave Foods is set to $19. Whitewave's shares closed at $16.25 on Friday.
BMO Capital upgraded First Majestic Silver (NYSE: AG) from “market perform” to “outperform.” The target price for First Majestic Silver has been lowered from $18 to $13. First Majestic Silver's shares closed at $10.59 on Friday.
Latest Ratings for BIIB
|Aug 2016||Morgan Stanley||Maintains||Overweight|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.